FDA to launch tool to detect fake, substandard malaria drugs

By Toni Clarke (Reuters) – The U.S. Food and Drug Administration has developed a hand-held device capable of identifying counterfeit or substandard malaria drugs and has signed a letter of intent with Corning Inc to manufacture the product. The device, known as CD-3, is a battery-operated tool that uses different wavelengths of light to compare an authentic malaria drug with a potentially fake product, the FDA said on Wednesday. Malaria is a potentially deadly mosquito-borne disease that often causes fever, chills and flu-like symptoms. …